New York Daily Ledger
SEE OTHER BRANDS

The latest news from New York

New York Daily Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New York Daily Ledger.

Press releases published on April 7, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Bancorp, Inc. of Class Action Lawsuit and Upcoming Deadlines - TBBK

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Bancorp, Inc. of Class Action Lawsuit and Upcoming Deadlines - TBBK

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against The Bancorp, Inc. (“Bancorp” or the “Company”) (NASDAQ: TBBK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw …

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Perpetua Resources Corp. of Class Action Lawsuit and Upcoming Deadlines - PPTA

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Perpetua Resources Corp. of Class Action Lawsuit and Upcoming Deadlines - PPTA

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Perpetua Resources Corp. (“Perpetua” or the “Company”) (NASDAQ: PPTA). Such investors are advised to contact Danielle Peyton at …

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Vita Coco Company, Inc. - COCO

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Vita Coco Company, Inc. (“Vita Coco” or the “Company”) (NASDAQ: COCO). Such investors are advised to contact Danielle Peyton at newaction@ …

CPI Aerostructures Delivers Airborne Pod Structure in Support of Northrop Grumman’s Airborne Laser Mine Detection Program for Korea

CPI Aerostructures Delivers Airborne Pod Structure in Support of Northrop Grumman’s Airborne Laser Mine Detection Program for Korea

EDGEWOOD, N.Y., April 07, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) announced today that they completed production and delivery of an Airborne Laser Mine Detection System (ALMDS) pod structure for …

Diamond Equity Research Initiates Coverage on Almonty Industries, Inc. (TSX: AII) (ASX: AII) (FWB: ALI) (OTCQX: ALMTF)

Diamond Equity Research Initiates Coverage on Almonty Industries, Inc. (TSX: AII) (ASX: AII) (FWB: ALI) (OTCQX: ALMTF)

New York, NY, April 07, 2025 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of Almonty Industries, Inc. (TSX: AII) (ASX: AII) (FWB: ALI) (OTCQX: ALMTF …

Aspargo Labs Expands Global Leadership Team

Aspargo Labs Expands Global Leadership Team

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. ("Aspargo Labs" or the "Company"), a specialty pharmaceutical and MedTech company focused on converting the world's most meaningful medications into liquid oral suspensions for delivery in …

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis (MS) and the other detailing the experience of …

Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer

Atwater Brewery Releases Atwater Light: Detroit’s Premium Light Craft Beer

DETROIT, April 07, 2025 (GLOBE NEWSWIRE) -- Atwater Brewing, Detroit’s renowned craft brewery and a craft beer brand of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is pleased to announce the launch of Atwater Light, a low-calorie, low-carb addition …

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia TNX-102 SL demonstrated statistically significant improvement in the primary endpoint of reduction in fibromyalgia …

FTAI Aviation Ltd. Announces Timing of First Quarter 2025 Earnings and Conference Call

FTAI Aviation Ltd. Announces Timing of First Quarter 2025 Earnings and Conference Call

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- FTAI Aviation Ltd. (NASDAQ: FTAI; the "Company" or “FTAI”) plans to announce its financial results for the first quarter 2025 after the closing of Nasdaq on Wednesday, April 30, 2025. A copy of the press release …

Elements of Amazon Music’s Shadowban of Marc Mysterio Exposed in Explosive 3-Part YouTube Series Depicting Evidence of Sophisticated Means Used to Subvert The Multi-Faceted Star

Elements of Amazon Music’s Shadowban of Marc Mysterio Exposed in Explosive 3-Part YouTube Series Depicting Evidence of Sophisticated Means Used to Subvert The Multi-Faceted Star

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- On February 27th, Marc Mysterio filed suit in the US District Court for the Southern District of New York (Case No. 1:25-cv-01705) against Amazon and DIstrokid alleging, inter alia, that he had not received …

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study

Participants with abnormal left ventricular mass index (LVMI) at baseline achieved 25% mean reduction in LVMI by 12 months or sooner Clinically meaningful improvements in majority of participants across cardiac biomarkers and functional measures All …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service